AAPL   373.85 (+2.68%)
MSFT   208.83 (+1.24%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.44 (-0.06%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
TSLA   1,208.66 (+0.00%)
AMD   53.40 (+2.03%)
T   30.55 (+1.56%)
ACB   12.27 (+0.00%)
F   6.20 (+2.48%)
DIS   113.82 (+1.46%)
BAC   23.80 (+2.19%)
NFLX   493.81 (+3.55%)
AAPL   373.85 (+2.68%)
MSFT   208.83 (+1.24%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.44 (-0.06%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
TSLA   1,208.66 (+0.00%)
AMD   53.40 (+2.03%)
T   30.55 (+1.56%)
ACB   12.27 (+0.00%)
F   6.20 (+2.48%)
DIS   113.82 (+1.46%)
BAC   23.80 (+2.19%)
NFLX   493.81 (+3.55%)
AAPL   373.85 (+2.68%)
MSFT   208.83 (+1.24%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.44 (-0.06%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
TSLA   1,208.66 (+0.00%)
AMD   53.40 (+2.03%)
T   30.55 (+1.56%)
ACB   12.27 (+0.00%)
F   6.20 (+2.48%)
DIS   113.82 (+1.46%)
BAC   23.80 (+2.19%)
NFLX   493.81 (+3.55%)
AAPL   373.85 (+2.68%)
MSFT   208.83 (+1.24%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.44 (-0.06%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
TSLA   1,208.66 (+0.00%)
AMD   53.40 (+2.03%)
T   30.55 (+1.56%)
ACB   12.27 (+0.00%)
F   6.20 (+2.48%)
DIS   113.82 (+1.46%)
BAC   23.80 (+2.19%)
NFLX   493.81 (+3.55%)
Log in

LON:UDGUdg Healthcare Share Price, Forecast & News

GBX 734.50
-0.50 (-0.07 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
727.50
Now: GBX 734.50
741.50
50-Day Range
593
MA: GBX 708.06
765.50
52-Week Range
423.40
Now: GBX 734.50
846
Volume336,344 shs
Average Volume981,360 shs
Market Capitalization£1.84 billion
P/E Ratio20.57
Dividend Yield2.17%
BetaN/A
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; and serialization solutions. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.
Read More
Udg Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Medical Distribution
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+353-1-4689000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£1.34 billion
Cash FlowGBX 66.54 per share
Book ValueGBX 377.60 per share

Profitability

Miscellaneous

Employees8,700
Market Cap£1.84 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive UDG News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG and its competitors with MarketBeat's FREE daily newsletter.

Udg Healthcare (LON:UDG) Frequently Asked Questions

How has Udg Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Udg Healthcare's stock was trading at GBX 628.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, UDG shares have increased by 16.9% and is now trading at GBX 734.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Udg Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Udg Healthcare in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Udg Healthcare.

How often does Udg Healthcare pay dividends? What is the dividend yield for Udg Healthcare?

Udg Healthcare declared a dividend on Tuesday, November 26th. Shareholders of record on Thursday, January 9th will be given a dividend of GBX 0.12 per share on Wednesday, February 5th. This represents a yield of 1.28%. The ex-dividend date of this dividend is Thursday, January 9th. This is an increase from Udg Healthcare's previous dividend of GBX 0.04. The official announcement can be accessed at this link. View Udg Healthcare's dividend history.

What price target have analysts set for UDG?

7 equities research analysts have issued 1-year target prices for Udg Healthcare's stock. Their forecasts range from GBX 735 to GBX 1,050. On average, they anticipate Udg Healthcare's stock price to reach GBX 874.29 in the next year. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Udg Healthcare.

Has Udg Healthcare been receiving favorable news coverage?

Press coverage about UDG stock has trended negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Udg Healthcare earned a news impact score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Udg Healthcare.

Who are some of Udg Healthcare's key competitors?

What other stocks do shareholders of Udg Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Udg Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), CRH (CRH), Standard Life Aberdeen (SL), Carclo (CAR), CBS (CBS), Greencore Group (GNC), Allergan (AGN), Aviva (AV) and AutoZone (AZO).

Who are Udg Healthcare's key executives?

Udg Healthcare's management team includes the following people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 56)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 45)
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications
  • Eleanor Garvey, Group Head of Quality & Compliance
  • Mr. Damien Moynagh, Gen. Counsel & Company Sec.

What is Udg Healthcare's stock symbol?

Udg Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "UDG."

How do I buy shares of Udg Healthcare?

Shares of UDG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Udg Healthcare's stock price today?

One share of UDG stock can currently be purchased for approximately GBX 734.50.

How big of a company is Udg Healthcare?

Udg Healthcare has a market capitalization of £1.84 billion and generates £1.34 billion in revenue each year. Udg Healthcare employs 8,700 workers across the globe.

What is Udg Healthcare's official website?

The official website for Udg Healthcare is www.udghealthcare.com.

How can I contact Udg Healthcare?

Udg Healthcare's mailing address is River Walk 20, DUBLIN,, Ireland. The company can be reached via phone at +353-1-4689000.

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.